ClinConnect ClinConnect Logo
Search / Trial NCT06809010

grouP O wholE blooD : storagE leSion impacT And infLammation

Launched by ETABLISSEMENT FRANÇAIS DU SANG · Feb 4, 2025

Trial Information

Current as of September 07, 2025

Recruiting

Keywords

Blood Lto Wb Characterization Of Labile Blood Products Whole Blood Apheresis Plasma Platelet Red Blood Cells Inflammation Transfusion

ClinConnect Summary

The PEDESTAL EFS study is looking at different types of blood products made from donations. Specifically, it will compare the effects of traditional blood products prepared by the Etablissement Français du Sang (EFS) with a new type called LTO-WB, made by the Centre de Transfusion Sanguine des Armées (CTSA). Researchers want to understand how these blood products affect inflammation and other biological factors in the body.

To join this study, you need to be a healthy blood donor aged between 18 and 70 years old (or 65 for those donating plasma or platelets). You should weigh at least 50 kg. If you meet these requirements and are interested, you can expect to participate in a safe environment where your contributions will help improve blood donation processes. Please note that the study has not started recruiting participants yet, so keep an eye out for updates if you're interested!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Self-referred donors eligible for blood donation (whole blood and/or platelet/plasma apheresis), meeting the following inclusion criteria:
  • Be in good health
  • Weigh at least 50 kg
  • Must be between 18 and 70 years of age for whole blood donation and between 18 and 65 years of age for plasma/platelet donation by apheresis.
  • Exclusion Criteria:
  • Subjects ineligible to donate blood

About Etablissement Français Du Sang

Etablissement Français du Sang (EFS) is a premier public health institution in France dedicated to the collection, testing, and distribution of blood and its components. As a key player in the national healthcare system, EFS ensures the safety and availability of blood products for patients in need, while also engaging in extensive research and clinical trials to advance transfusion medicine and improve patient outcomes. With a strong commitment to innovation and public service, EFS collaborates with healthcare professionals, researchers, and regulatory bodies to enhance blood safety, develop new therapeutic applications, and respond effectively to the evolving needs of the healthcare community.

Locations

Saint Etienne, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported